VENTRUS BIOSCIENCES ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Ventrus Biosciences, Inc. of

  VENTRUS BIOSCIENCES ALERT: Levi & Korsinsky Notifies Investors with Losses
  on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and
  the Deadline of July 8, 2013 to Seek a Lead Plaintiff Position

Business Wire

NEW YORK -- June 18, 2013

Levi & Korsinsky announces that a class action lawsuit has been commenced in
the United States District Court for the Southern District of New York on
behalf of investors who purchased Ventrus Biosciences, Inc. (“Ventrus” or the
“Company”) (NasdaqCM: VTUS) stock between December 17, 2010 and June 25, 2012
(the “Class Period”).

For more information, click here: 
http://zlk.9nl.com/ventrus-biosciences-vtus/.

The complaint alleges that during the Class Period, defendants issued
materially false and misleading statements and omitted materially relevant
facts regarding iferanserin (VEN 309) (“VEN 309”), the Company’s chemical
entity for the treatment of internal hemorrhoids. On June 25, 2012, Ventrus
announced that VEN 309 had failed its Phase III trial before the FDA and that
the Company was abandoning plans for further development of the treatment. In
response to this news, the price of Ventrus common stock fell over 50% from a
close of $12.26 on June 22, 2012 to a close of $5.02 per share on June 25,
2012.

If you suffered a loss in Ventrus you have until July 8, 2013  to request that
the Court appoint you as lead plaintiff. Your ability to share in any recovery
doesn’t require that you serve as a lead plaintiff. To obtain additional
information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or
by telephone at (877) 363-5972, or visit
http://zlk.9nl.com/ventrus-biosciences-vtus/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

Contact:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
jlevi@zlk.com
(877) 363-5972
 
Press spacebar to pause and continue. Press esc to stop.